Allient (ALNT) Competitors $30.92 -0.92 (-2.89%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$30.98 +0.06 (+0.21%) As of 05/21/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALNT vs. TXG, TRNS, LAB, EYPT, SENS, CTKB, QSI, AEHR, QTRX, and MASSShould you be buying Allient stock or one of its competitors? The main competitors of Allient include 10x Genomics (TXG), Transcat (TRNS), Standard BioTools (LAB), EyePoint Pharmaceuticals (EYPT), Senseonics (SENS), Cytek Biosciences (CTKB), Quantum-Si (QSI), Aehr Test Systems (AEHR), Quanterix (QTRX), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry. Allient vs. 10x Genomics Transcat Standard BioTools EyePoint Pharmaceuticals Senseonics Cytek Biosciences Quantum-Si Aehr Test Systems Quanterix 908 Devices Allient (NASDAQ:ALNT) and 10x Genomics (NASDAQ:TXG) are both small-cap computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, community ranking, earnings and dividends. Do analysts recommend ALNT or TXG? Allient presently has a consensus target price of $31.00, suggesting a potential upside of 0.26%. 10x Genomics has a consensus target price of $15.81, suggesting a potential upside of 90.00%. Given 10x Genomics' higher probable upside, analysts plainly believe 10x Genomics is more favorable than Allient.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Allient 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.5010x Genomics 1 Sell rating(s) 8 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.38 Which has preferable earnings and valuation, ALNT or TXG? Allient has higher earnings, but lower revenue than 10x Genomics. 10x Genomics is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAllient$516.06M1.01$24.10M$0.5952.4110x Genomics$624.66M1.63-$182.63M-$1.30-6.40 Which has more volatility & risk, ALNT or TXG? Allient has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Comparatively, 10x Genomics has a beta of 1.94, suggesting that its stock price is 94% more volatile than the S&P 500. Does the media refer more to ALNT or TXG? In the previous week, 10x Genomics had 6 more articles in the media than Allient. MarketBeat recorded 13 mentions for 10x Genomics and 7 mentions for Allient. Allient's average media sentiment score of 1.15 beat 10x Genomics' score of 0.90 indicating that Allient is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Allient 5 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive 10x Genomics 7 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of ALNT or TXG? 61.6% of Allient shares are held by institutional investors. Comparatively, 84.7% of 10x Genomics shares are held by institutional investors. 14.9% of Allient shares are held by insiders. Comparatively, 9.4% of 10x Genomics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community believe in ALNT or TXG? 10x Genomics received 59 more outperform votes than Allient when rated by MarketBeat users. However, 54.55% of users gave Allient an outperform vote while only 50.39% of users gave 10x Genomics an outperform vote. CompanyUnderperformOutperformAllientOutperform Votes654.55% Underperform Votes545.45% 10x GenomicsOutperform Votes6550.39% Underperform Votes6449.61% Is ALNT or TXG more profitable? Allient has a net margin of 2.64% compared to 10x Genomics' net margin of -29.90%. Allient's return on equity of 10.80% beat 10x Genomics' return on equity.Company Net Margins Return on Equity Return on Assets Allient2.64% 10.80% 4.75% 10x Genomics -29.90%-25.40%-19.69% SummaryAllient beats 10x Genomics on 10 of the 18 factors compared between the two stocks. Get Allient News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALNT vs. The Competition Export to ExcelMetricAllientInstruments to measure electricity IndustryComputer SectorNASDAQ ExchangeMarket Cap$523.45M$4.14B$25.10B$8.39BDividend Yield0.37%0.46%2.90%4.10%P/E Ratio35.1422.1144.5819.71Price / Sales1.012.382,122.69117.39Price / Cash6.8617.8734.7834.62Price / Book1.993.246.654.50Net Income$24.10M$135.28M$739.99M$248.18M7 Day Performance-5.65%-1.10%-0.92%0.20%1 Month Performance47.94%12.05%12.60%12.37%1 Year Performance9.53%-8.84%52,628.85%7.04% Allient Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALNTAllient2.6284 of 5 stars$30.92-2.9%$31.00+0.3%+6.1%$523.45M$516.06M35.141,950Positive NewsTXG10x Genomics4.4874 of 5 stars$9.49+8.2%$17.81+87.6%-65.3%$1.16B$624.66M-6.241,240Analyst ForecastGap DownTRNSTranscat1.895 of 5 stars$82.39+4.7%$111.50+35.3%-36.3%$766.97M$272.20M44.54920Earnings ReportAnalyst UpgradeLABStandard BioTools2.3303 of 5 stars$1.16+8.4%$2.50+115.5%-59.7%$440.59M$169.69M-1.63620Positive NewsEYPTEyePoint Pharmaceuticals2.0845 of 5 stars$5.85+0.7%$25.29+332.2%-49.4%$402.54M$43.27M-2.93120Analyst RevisionSENSSenseonics2.0371 of 5 stars$0.60-4.0%$2.00+233.3%+6.4%$392.53M$22.47M-4.6290CTKBCytek Biosciences1.9708 of 5 stars$3.02+3.4%$5.25+73.8%-58.8%$385.35M$197.05M-37.75500News CoverageQSIQuantum-Si2.6439 of 5 stars$1.51+19.8%$3.48+130.1%-14.7%$276.54M$3.06M-2.36150Earnings ReportAnalyst ForecastAnalyst RevisionGap UpAEHRAehr Test Systems3.9035 of 5 stars$9.11+7.8%$25.00+174.4%-26.3%$271.21M$61.48M12.1590Positive NewsQTRXQuanterix1.8227 of 5 stars$5.73+8.5%$16.20+182.7%-71.3%$204.81M$135.44M-5.41460Positive NewsGap UpMASS908 Devices2.9359 of 5 stars$5.73+2.0%$5.33-6.9%-28.2%$204.79M$59.63M-3.2460Analyst RevisionGap Up Related Companies and Tools Related Companies 10x Genomics Alternatives Transcat Alternatives Standard BioTools Alternatives EyePoint Pharmaceuticals Alternatives Senseonics Alternatives Cytek Biosciences Alternatives Quantum-Si Alternatives Aehr Test Systems Alternatives Quanterix Alternatives 908 Devices Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALNT) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allient Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allient With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALNT Stock Free ALNT Stock Alerts